Haleon plc (NYSE:HLN) Sees Significant Growth in Short Interest

Haleon plc (NYSE:HLN) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 16,990,000 shares, an increase of 36.8% from the November 30th total of 12,420,000 shares. Approximately 0.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 6,840,000 shares, the short-interest ratio is currently 2.5 days.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Fortitude Family Office LLC purchased a new position in Haleon during the 3rd quarter valued at $28,000. Toronto Dominion Bank increased its stake in Haleon by 3,470.0% in the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after purchasing an additional 3,470 shares during the period. Prospera Private Wealth LLC bought a new stake in shares of Haleon during the third quarter worth $57,000. BOKF NA boosted its stake in shares of Haleon by 68.8% during the second quarter. BOKF NA now owns 6,972 shares of the company’s stock valued at $58,000 after purchasing an additional 2,842 shares during the period. Finally, Rothschild Investment LLC bought a new position in shares of Haleon in the second quarter worth about $60,000. Institutional investors own 6.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. UBS Group raised shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Morgan Stanley lifted their target price on Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a report on Friday, September 20th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Haleon has an average rating of “Buy” and an average target price of $10.95.

Haleon Trading Down 1.3 %

Shares of HLN stock traded down $0.13 during trading hours on Monday, reaching $9.51. 6,218,063 shares of the stock were exchanged, compared to its average volume of 5,428,227. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon has a 12-month low of $7.89 and a 12-month high of $10.80. The firm has a market capitalization of $43.05 billion, a price-to-earnings ratio of 27.97, a price-to-earnings-growth ratio of 2.95 and a beta of 0.28. The company’s 50-day moving average price is $9.68 and its 200-day moving average price is $9.62.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.